Elizabeth Yeu Lin, Chief Medical Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 1,144 shares at $69.42 ($78K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Open-market sale of $78k TARS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.42 | 375 | $26K | 33.3% |
| 2 | $68.71 | 379 | $26K | 33.3% |
| 3 | $67.00 | 390 | $26K | 33.4% |
| Total | $68.36 avg | 1,144 | $78K | 100% |
| Filing → |
| TARS | SELL | 2025-12-17 | $165K | — | Filing → |
| TARS | SELL | 2025-06-17 | $41K | — | Filing → |
| STAA | BUY | 2023-09-22 | $100K | — | Filing → |